Navigation Links
New study reveals long delays and variability are losing the UK research and jobs
Date:2/22/2010

Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.

The two year study focused on identifying the key social, organisational and managerial factors that influence clinical research projects in the UK. In the first study of its kind, the researchers carried out a national survey in which they interviewed key stakeholders and surveyed 247 clinical research projects about the challenges of managing clinical research. The study found that although patient recruitment was and remains a major challenge, retaining the project team was seen as critical to the ongoing success of clinical research and that this was becoming increasingly difficult. Additionally the research found that retaining the research team throughout the project was significantly hampered by aspects of the approval process; projects which had been approved by the regulatory bodies often then encountered difficulty in obtaining approval from the hospital Trusts and that there was huge variation in both the time and requirements needed to gain approval from these Trusts.

Professor Jacky Swan of Warwick Business School commented, "The problem is that to commercial organisations, time is very important and although many are committed to carrying out clinical research in this country, many are finding it easier to do this research abroad and that does have long term and significant implications for high quality research in the UK and also for the retention of skilled researchers." Additionally, Professor Swan stressed that the inconsistencies and lengthiness of the approvals processes has a detrimental effect on the completion rates of non- commercial organisations. "There are three elements of approval; regulation, ethics and research and development and although there has been improvement in regulation and there have been efforts to streamline the R&D process, these are not happening quickly enough to have a positive impact." she added.

"Far more policy attention is needed to address these problems; especially around the skills shortages that are emerging and aspects of the NHS culture which are making it very difficult to conduct the innovative, world-leading clinical research that the UK has always been known for." added Maxine Robertson, Professor of Innovation and Organisation at Queen Mary, University of London.


'/>"/>

Contact: Professor Jacky Swan
Jacky.Swan@wbs.ac.uk
44-024-765-24271
University of Warwick
Source:Eurekalert

Related medicine news :

1. More Bars Equals More Assaults, Study Finds
2. Webmarketing 123 Profiled in National Study of High Growth Professional Services Firms
3. CapSite Announces Release of the 2010 U.S. Ambulatory EHR Study
4. International study confirms doubling of childhood leukemia rates in southern Iraq
5. Dolphins could be ideal model to study human cervical cancer, UF veterinarians say
6. UCLA study reveals how genes interact with their environment to cause disease
7. Battlefield camaraderie yields long-term dividends for veterans, study finds
8. UAB-led study shows simple steps could reduce stillbirths by up to 1 million
9. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
10. Study supports alternative anti-seizure medication following acute brain injury
11. Scripps Health Begins Pioneering Study of Human Tumor Sequencing in Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... On ... Best Places to Work in the Research Triangle for 2017. , Winners were ... company had to meet a threshold in employee participation--a percentage that varies based ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... the much-anticipated fall event , Look Awesome This Autumn with CoolSculpting®. Scheduled ... special pricing and refreshments. , Mirror Mirror Beauty Boutique is Houston’s largest ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud to ... Guard®, has helped another long-time client pass their Department of Health and Human ... law. , Thanks to the help of the Compliancy Group's Audit Response Program™, ...
(Date:9/20/2017)... ... 2017 , ... Five consumer packaged goods (CPG) products were selected by the ... Nopavera Plus was named to the short list in the Specialty Supplements ... during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay Bay Resort ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... feel good program from Leany Greeny delivers positive results in just three weeks. ... health and kickstart the metabolism. Fitting seamlessly into hectic work and family schedules, ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
(Date:9/5/2017)... announced another milestone in their continued growth and success of the company.  Xyntek ... customer engagements regionally.  ... located at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support ... In addition to Xyntek,s ...
Breaking Medicine Technology: